CVI Investments, Inc. 13D and 13G filings for Theriva Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-02-07 4:10 pm Purchase | 2024-12-31 | 13G | Theriva Biologics, Inc. TOVX | CVI Investments, Inc. | 146,136 4.900% | 146,136![]() (New Position) | Filing |